Research graph
References from Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Sofosbuvir/velpatasvir pharmacokinetics, safety, and efficacy in pregnant people with hepatitis C virus
10.1093/cid/ciae595 · 2025 · External reference
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study
10.1016/s2666-5247(20)30062-8 · 2020 · External reference
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
10.1002/hep.21178 · 2006 · External reference
Hepatitis C and obstetrical morbidity in a substance use disorder clinic: a role for telemedicine?
10.1016/j.ajogmf.2023.101219 · 2024 · External reference
Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014
10.2105/ajph.2017.304132 · 2018 · External reference
Risk factors for perinatal transmission of hepatitis C virus
10.1097/aog.0000000000005306 · 2023 · External reference
Reported prevalence of maternal hepatitis C virus infection in the United States
10.1097/aog.0000000000003644 · 2020 · External reference
Society for maternal-fetal medicine consult series #56: hepatitis C in pregnancy—updated guidelines: replaces consult number 43, November 2017
10.1016/j.ajog.2021.06.008 · 2021 · External reference
Postpartum follow-up care for pregnant persons with opioid use disorder and hepatitis C infection
10.1097/aog.0000000000004760 · 2022 · External reference
Unresolved reference
External reference
